MARÍA DOLORES
CABALLERO BARRIGÓN
Investigadora en el periodo 1998-2022
Fred Hutchinson Cancer Research Center
Seattle, Estados UnidosPublicaciones en colaboración con investigadores/as de Fred Hutchinson Cancer Research Center (4)
2023
2018
-
Ibrutinib as treatment for patients with relapsed/refractory follicular lymphoma: Results from the open-label, multicenter, phase II DAWN study
Journal of Clinical Oncology, Vol. 36, Núm. 23, pp. 2405-2412
2017
-
FDG-PET is prognostic and predictive for progression-free survival in relapsed follicular lymphoma: exploratory analysis of the GAUSS study
Leukemia and Lymphoma, Vol. 58, Núm. 2, pp. 372-381